Valsalva maneuver

Introduction

The Valsalva maneuver is a controlled technique involving a forceful exhalation against a closed airway, typically the glottis. It is widely used in both clinical and physiological settings to assess cardiovascular function, terminate certain arrhythmias, and study autonomic nervous system responses. Understanding its mechanism and effects is essential for safe and effective application.

Anatomy and Physiology Relevant to the Valsalva Maneuver

Respiratory system

The respiratory system provides the framework for generating intrathoracic pressure during the Valsalva maneuver:

• Lungs and airways: Act as reservoirs for air and create the pathway for pressure generation.
• Diaphragm and accessory muscles: Contract to increase intra-abdominal and intrathoracic pressure during forced exhalation against a closed glottis.

Cardiovascular system

The cardiovascular system is directly affected by changes in intrathoracic pressure:

• Heart chambers and valves: Changes in venous return and cardiac output occur as intrathoracic pressure fluctuates.
• Great vessels: The aorta and vena cavae are influenced by pressure changes that affect preload and afterload.
• Autonomic nervous system: Baroreceptors and chemoreceptors modulate heart rate and vascular tone in response to hemodynamic changes.

Intra-thoracic and intra-abdominal pressures

The Valsalva maneuver relies on creating high pressures within the thoracic and abdominal cavities:

• Pressure changes reduce venous return to the heart, temporarily decreasing cardiac output.
• Release of the maneuver leads to a sudden increase in venous return and transient blood pressure changes.

Definition and Mechanism

The Valsalva maneuver is defined as a deliberate increase in intrathoracic and intra-abdominal pressure by exhaling forcefully against a closed glottis. This maneuver produces characteristic physiological changes in cardiovascular and autonomic function.

• Phases of the maneuver:
  • Phase I: Onset of strain causes a transient increase in intrathoracic pressure and arterial blood pressure.
  • Phase II: Continued strain decreases venous return, lowering cardiac output and blood pressure, with reflex tachycardia.
  • Phase III: Release of strain causes a brief drop in blood pressure as intrathoracic pressure normalizes.
  • Phase IV: Venous return and cardiac output rebound, resulting in a transient overshoot of blood pressure and reflex bradycardia.
• Physiological effects: Modulates heart rate, blood pressure, and autonomic nervous system activity through baroreceptor-mediated reflexes.

Clinical Applications

Diagnostic uses

The Valsalva maneuver is employed as a diagnostic tool in cardiovascular and autonomic assessment:

• Evaluates autonomic nervous system integrity by monitoring heart rate and blood pressure responses.
• Assists in the assessment of heart murmurs and valvular function by altering intracardiac pressures.
• Helps detect arrhythmias and conduction abnormalities during cardiac evaluation.

Therapeutic uses

The maneuver has therapeutic applications in specific medical conditions:

• Termination of supraventricular tachycardia by increasing vagal tone.
• Reduction of elevated intracranial or intraocular pressures in certain scenarios.
• Assistance in defecation or urination through increased abdominal pressure.

Other applications

Additional uses include physiological adaptations in specialized environments:

• Equalization of middle ear pressure during aviation or scuba diving.
• Research in aerospace medicine to study cardiovascular responses to pressure changes.

Physiological Effects

Cardiovascular responses

The Valsalva maneuver induces significant changes in cardiovascular function due to alterations in intrathoracic pressure:

• Initial rise in arterial blood pressure during Phase I due to compression of the aorta.
• Decreased venous return and stroke volume during Phase II, often accompanied by reflex tachycardia.
• Overshoot of blood pressure and reflex bradycardia during Phase IV as venous return and cardiac output normalize.

Respiratory effects

The maneuver affects respiratory mechanics and gas exchange:

• Increased intrathoracic pressure reduces lung expansion and airflow temporarily.
• Changes in alveolar ventilation can alter oxygen and carbon dioxide levels.
• May assist in equalizing pressure in the middle ear and sinuses.

Neurological and autonomic responses

The autonomic nervous system modulates the physiological changes during the maneuver:

• Baroreceptor reflexes respond to blood pressure fluctuations by adjusting heart rate and vascular tone.
• Sympathetic activation occurs during decreased cardiac output, while parasympathetic activity increases during the blood pressure overshoot.

Technique

The Valsalva maneuver can be performed safely using the following steps:

• Instruct the patient to take a deep breath and hold it.
• Exhale forcefully against a closed glottis, typically for 10 to 15 seconds.
• Observe cardiovascular and respiratory responses during the strain and release phases.
• Variations include performing the maneuver while seated, supine, or using specialized devices for clinical testing.

Precautions should be taken in patients with cardiovascular disease, uncontrolled hypertension, or recent myocardial infarction, as the maneuver can provoke adverse events.

Complications and Risks

Although generally safe, the Valsalva maneuver can cause complications in certain individuals, particularly those with underlying cardiovascular or cerebrovascular conditions.

• Cardiovascular complications: Arrhythmias, transient hypotension, syncope, or, rarely, myocardial ischemia.
• Neurological risks: Increased intracranial pressure may exacerbate cerebral aneurysms or cause transient headache and dizziness.
• Ophthalmologic considerations: Elevation of intraocular pressure may worsen glaucoma or lead to retinal hemorrhage in rare cases.
• Special populations: Caution is advised in elderly patients, those with uncontrolled hypertension, or recent cardiac events.

Prognosis and Outcomes

The outcomes of the Valsalva maneuver depend on the purpose for which it is used and the health status of the individual.

• Healthy individuals: Generally experience predictable physiological responses without adverse effects.
• Therapeutic use: Effective for terminating supraventricular tachycardia when performed correctly, with rapid resolution of arrhythmia.
• Diagnostic use: Provides reliable information about autonomic function and cardiovascular status in controlled settings.
• At-risk individuals: Patients with cardiac or cerebrovascular disease may require monitoring, but serious complications remain uncommon with appropriate precautions.

References

1. Longhurst JC, et al. The Valsalva maneuver: physiology and clinical applications. Circulation. 2010;122(15):1562-1570.
2. Feldman RL, et al. Cardiovascular and autonomic responses to the Valsalva maneuver. J Clin Monit Comput. 2015;29(2):123-134.
3. Guyton AC, Hall JE. Textbook of Medical Physiology. 14th ed. Elsevier; 2020.
4. Marieb EN, Hoehn K. Human Anatomy & Physiology. 11th ed. Pearson; 2019.
5. Parati G, et al. Valsalva maneuver in clinical practice. J Hypertens. 2013;31(5):849-857.
6. Sharma V, et al. Autonomic testing with Valsalva maneuver: clinical applications. Clin Auton Res. 2017;27(6):381-391.
7. American Heart Association. Supraventricular tachycardia: management guidelines. Circulation. 2018;138:e659-e673.
8. Brooks VL, et al. Cardiovascular effects of the Valsalva maneuver. Compr Physiol. 2016;6(1):69-82.
9. Khurana RK. Textbook of Electrocardiography and Arrhythmias. 4th ed. Elsevier; 2018.